# Urban One, Inc.: financial statements, quarterly

UONE · Nasdaq · CIK 1041657 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uone.md) · [Financials](/companies/uone/financials.md) · [Filings](/companies/uone/filings.md) · [Insiders](/companies/uone/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/uone/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [118](/filings/0001041657-24-000020.md) | [120 d](/filings/0001041657-25-000013.md) | [104](/filings/0001041657-25-000034.md) | [118](/filings/0001041657-25-000042.md) | [110](/filings/0001041657-25-000054.md) | [117 d](/filings/0001041657-26-000016.md) | [92.2](/filings/0001041657-26-000034.md) | [91.6](/filings/0001041657-26-000053.md) | [92.7](/filings/0001041657-25-000054.md) | [97.8 d](/filings/0001041657-26-000016.md) | [77.7](/filings/0001041657-26-000034.md) | [85.8](/filings/0001041657-26-000053.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [40.4](/filings/0001041657-24-000020.md) | [46.4 d](/filings/0001041657-25-000013.md) | [57.0](/filings/0001041657-25-000034.md) | [61.2](/filings/0001041657-25-000042.md) | [54.6](/filings/0001041657-25-000054.md) | [57.7 d](/filings/0001041657-26-000016.md) | [50.8](/filings/0001041657-26-000034.md) | [50.1](/filings/0001041657-26-000053.md) | [49.3](/filings/0001041657-25-000054.md) | [59.0 d](/filings/0001041657-26-000016.md) | [43.7](/filings/0001041657-26-000034.md) | [46.9](/filings/0001041657-26-000053.md) |
| Operating income | $m | [(56.1)](/filings/0001041657-24-000020.md) | [6.8 d](/filings/0001041657-25-000013.md) | [12.9](/filings/0001041657-25-000034.md) | [(60.4)](/filings/0001041657-25-000042.md) | [(26.2)](/filings/0001041657-25-000054.md) | [(1.9) d](/filings/0001041657-26-000016.md) | [2.1](/filings/0001041657-26-000034.md) | [(121)](/filings/0001041657-26-000053.md) | [2.5](/filings/0001041657-25-000054.md) | [(54.0) d](/filings/0001041657-26-000016.md) | [(2.2)](/filings/0001041657-26-000034.md) | [(11.2)](/filings/0001041657-26-000053.md) |
| Interest expense | $m | [14.0](/filings/0001558370-23-019998.md) | [14.2 d](/filings/0001558370-24-009018.md) | [13.0](/filings/0001558370-24-009019.md) | [12.4](/filings/0001041657-25-000042.md) | [11.6](/filings/0001041657-25-000054.md) | [11.5 d](/filings/0001041657-26-000016.md) | [10.9](/filings/0001041657-26-000034.md) | [9.7](/filings/0001041657-26-000053.md) | [9.4](/filings/0001041657-25-000054.md) | [8.7 d](/filings/0001041657-26-000016.md) | [4.4](/filings/0001041657-26-000034.md) | [2.1](/filings/0001041657-26-000053.md) |
| Income tax | $m | [(16.8)](/filings/0001041657-24-000020.md) | [2.7 d](/filings/0001041657-25-000013.md) | [2.5](/filings/0001041657-25-000034.md) | [(18.5)](/filings/0001041657-25-000042.md) | [(1.8)](/filings/0001041657-25-000054.md) | [27.6 d](/filings/0001041657-26-000016.md) | [15.7](/filings/0001041657-26-000034.md) | [(21.4)](/filings/0001041657-26-000053.md) | [(1.1)](/filings/0001041657-25-000054.md) | [(9.2) d](/filings/0001041657-26-000016.md) | [(1.4)](/filings/0001041657-26-000034.md) | [(1.7)](/filings/0001041657-26-000053.md) |
| Net income | $m | [(54.4)](/filings/0001041657-24-000020.md) | [(11.0) d](/filings/0001041657-25-000013.md) | [7.5](/filings/0001041657-25-000054.md) | [(45.4)](/filings/0001041657-25-000054.md) | [(31.8)](/filings/0001041657-25-000054.md) | [(35.7) d](/filings/0001041657-26-000016.md) | [(11.7)](/filings/0001041657-26-000034.md) | [(77.9)](/filings/0001041657-26-000053.md) | [(2.8)](/filings/0001041657-25-000054.md) | [(54.4) d](/filings/0001041657-26-000016.md) | [(3.1)](/filings/0001041657-26-000034.md) | [(7.1)](/filings/0001041657-26-000053.md) |
| Diluted EPS | $ per share | [(1.14)](/filings/0001041657-24-000020.md) | not reported | [0.15](/filings/0001041657-25-000034.md) | [(0.94)](/filings/0001041657-25-000042.md) | [(0.68)](/filings/0001041657-25-000054.md) | not reported | [(2.64)](/filings/0001041657-26-000034.md) | [(17.41)](/filings/0001041657-26-000053.md) | [(0.06)](/filings/0001041657-25-000054.md) | not reported | [(0.69)](/filings/0001041657-26-000034.md) | [(1.58)](/filings/0001041657-26-000053.md) |
| Basic EPS | $ per share | [(1.14)](/filings/0001041657-24-000020.md) | not reported | [0.15](/filings/0001041657-25-000034.md) | [(0.94)](/filings/0001041657-25-000042.md) | [(0.68)](/filings/0001041657-25-000054.md) | not reported | [(2.64)](/filings/0001041657-26-000034.md) | [(17.41)](/filings/0001041657-26-000053.md) | [(0.06)](/filings/0001041657-25-000054.md) | not reported | [(0.69)](/filings/0001041657-26-000034.md) | [(1.58)](/filings/0001041657-26-000053.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [196](/filings/0001041657-24-000020.md) | [233](/filings/0001041657-25-000013.md) | [155](/filings/0001041657-25-000034.md) | [132](/filings/0001041657-25-000042.md) | [115](/filings/0001041657-25-000054.md) | [137](/filings/0001041657-26-000016.md) | [115](/filings/0001041657-26-000034.md) | [85.7](/filings/0001041657-26-000053.md) | [79.3](/filings/0001041657-25-000054.md) | [25.5](/filings/0001041657-26-000053.md) | [27.2](/filings/0001041657-26-000034.md) | [15.4](/filings/0001041657-26-000053.md) |
| Current assets | $m | [394](/filings/0001558370-23-019998.md) | [422](/filings/0001041657-25-000013.md) | [335](/filings/0001558370-24-009019.md) | [309](/filings/0001041657-24-000006.md) | [292](/filings/0001041657-24-000020.md) | [305](/filings/0001041657-26-000016.md) | [264](/filings/0001041657-25-000034.md) | [233](/filings/0001041657-25-000042.md) | [229](/filings/0001041657-25-000054.md) | [164](/filings/0001041657-26-000053.md) | [150](/filings/0001041657-26-000034.md) | [148](/filings/0001041657-26-000053.md) |
| Total assets | $m | [1,192](/filings/0001558370-23-019998.md) | [1,211](/filings/0001041657-25-000013.md) | [1,126](/filings/0001558370-24-009019.md) | [1,020](/filings/0001041657-24-000006.md) | [963](/filings/0001041657-24-000020.md) | [945](/filings/0001041657-26-000016.md) | [891](/filings/0001041657-25-000034.md) | [729](/filings/0001041657-25-000042.md) | [723](/filings/0001041657-25-000054.md) | [593](/filings/0001041657-26-000053.md) | [573](/filings/0001041657-26-000034.md) | [552](/filings/0001041657-26-000053.md) |
| Current liabilities | $m | [105](/filings/0001558370-23-019998.md) | [133](/filings/0001041657-25-000013.md) | [114](/filings/0001558370-24-009019.md) | [112](/filings/0001041657-24-000006.md) | [100](/filings/0001041657-24-000020.md) | [114](/filings/0001041657-26-000016.md) | [89.0](/filings/0001041657-25-000034.md) | [88.4](/filings/0001041657-25-000042.md) | [88.6](/filings/0001041657-25-000054.md) | [78.3](/filings/0001041657-26-000053.md) | [81.6](/filings/0001041657-26-000034.md) | [80.3](/filings/0001041657-26-000053.md) |
| Total liabilities | $m | [892](/filings/0001558370-23-019998.md) | [921](/filings/0001041657-25-000013.md) | [832](/filings/0001558370-24-009019.md) | [771](/filings/0001041657-24-000006.md) | [747](/filings/0001041657-24-000020.md) | [766](/filings/0001041657-26-000016.md) | [728](/filings/0001041657-25-000034.md) | [644](/filings/0001041657-25-000042.md) | [642](/filings/0001041657-25-000054.md) | [566](/filings/0001041657-26-000053.md) | [550](/filings/0001041657-26-000034.md) | [532](/filings/0001041657-26-000053.md) |
| Long-term debt | $m | [716](/filings/0001558370-23-019998.md) | [716](/filings/0001041657-25-000013.md) | [643](/filings/0001558370-24-009019.md) | [608](/filings/0001041657-24-000006.md) | [594](/filings/0001041657-24-000020.md) | [579](/filings/0001041657-26-000016.md) | [551](/filings/0001041657-25-000034.md) | [488](/filings/0001041657-25-000042.md) | [484](/filings/0001041657-25-000054.md) | [430](/filings/0001041657-26-000053.md) | [412](/filings/0001041657-26-000034.md) | [399](/filings/0001041657-26-000053.md) |
| Current portion of debt | $m | [0.0](/filings/0001558370-23-019998.md) | [0.0](/filings/0001558370-24-009018.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001041657-26-000016.md) | not reported | not reported | not reported | [10.0](/filings/0001041657-26-000053.md) | [10.0](/filings/0001041657-26-000034.md) | [20.0](/filings/0001041657-26-000053.md) |
| Shareholders' equity | $m | [279](/filings/0001558370-23-019998.md) | [274](/filings/0001041657-25-000013.md) | [285](/filings/0001558370-24-009019.md) | [239](/filings/0001041657-24-000006.md) | [205](/filings/0001041657-24-000020.md) | [171](/filings/0001041657-26-000016.md) | [159](/filings/0001041657-25-000034.md) | [82.2](/filings/0001041657-25-000042.md) | [78.8](/filings/0001041657-25-000054.md) | [24.6](/filings/0001041657-26-000053.md) | [23.0](/filings/0001041657-26-000034.md) | [16.3](/filings/0001041657-26-000053.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.5 d](/filings/0001041657-24-000020.md) | [21.3 d](/filings/0001041657-25-000013.md) | [(2.5)](/filings/0001041657-25-000034.md) | [6.2 d](/filings/0001041657-25-000042.md) | [(1.8) d](/filings/0001041657-25-000054.md) | [35.6 d](/filings/0001041657-26-000016.md) | [2.1](/filings/0001041657-26-000034.md) | [6.2 d](/filings/0001041657-26-000053.md) | [(0.2) d](/filings/0001041657-25-000054.md) | [(4.0) d](/filings/0001041657-26-000016.md) | [22.1](/filings/0001041657-26-000034.md) | [(7.3) d](/filings/0001041657-26-000053.md) |
| Capital expenditure | $m | [2.5](/filings/0001041657-24-000020.md) | [1.1 d](/filings/0001041657-25-000013.md) | [1.8](/filings/0001041657-25-000034.md) | [2.2](/filings/0001041657-25-000042.md) | [1.6](/filings/0001041657-25-000054.md) | [1.6 d](/filings/0001041657-26-000016.md) | [2.5](/filings/0001041657-26-000034.md) | [1.2](/filings/0001041657-25-000042.md) | [3.1](/filings/0001041657-25-000054.md) | [3.2 d](/filings/0001041657-26-000016.md) | [3.4](/filings/0001041657-26-000034.md) | [1.7 d](/filings/0001041657-26-000053.md) |
| Share repurchases | $m | [0.2 d](/filings/0001041657-24-000020.md) | [0.0 d](/filings/0001041657-25-000013.md) | [1.4](/filings/0001041657-25-000034.md) | [1.1 d](/filings/0001041657-25-000042.md) | [2.8 d](/filings/0001041657-25-000054.md) | [2.8 d](/filings/0001041657-26-000016.md) | [1.0](/filings/0001041657-26-000034.md) | [0.7 d](/filings/0001041657-26-000053.md) | [0.8 d](/filings/0001041657-25-000054.md) | [0.2 d](/filings/0001041657-26-000016.md) | [0.0](/filings/0001041657-26-000034.md) | [1.2 d](/filings/0001041657-26-000053.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [50.2](/filings/0001558370-23-019998.md) | [47.4](/filings/0001558370-24-009019.md) | [50.6](/filings/0001041657-24-000006.md) | [47.7](/filings/0001041657-24-000020.md) | [49.9](/filings/0001041657-25-000034.md) | [48.5](/filings/0001041657-25-000042.md) | [47.1](/filings/0001041657-25-000054.md) | [4.4](/filings/0001041657-26-000034.md) | [4.5](/filings/0001041657-26-000053.md) | [44.4](/filings/0001041657-25-000054.md) | [4.4](/filings/0001041657-26-000034.md) | [4.5](/filings/0001041657-26-000053.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.